Teh Jiasian, Kinnear Ned, Douglass-Molloy Hannah, Hennessey Derek Barrry
Austin Hospital, Heidelberg, Victoria, Australia.
Royal Adelaide Hospital, Adelaide, South Australia, Australia.
BMJ Case Rep. 2017 Jan 25;2017:bcr2016218270. doi: 10.1136/bcr-2016-218270.
A 49-year-old woman with cutaneous and uterine leiomyomas, flank pain and a family history of hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome sought genetic testing. She was found to harbour a fumarate hydratase (FH) genetic mutation and a previously undetected renal tumour. The patient underwent radical nephrectomy, and remains well at follow-up. HLRCC syndrome is a rare autosomal dominant disease, with patients at increased risk for cutaneous leiomyomas, early-onset uterine leiomyomas and aggressive renal carcinoma. Although the syndrome may manifest life-threatening complications, outcomes may be improved by preventative family screening and surveillance, compelling early diagnosis.
一名49岁患有皮肤和子宫平滑肌瘤、胁腹疼痛且有遗传性平滑肌瘤病和肾细胞癌(HLRCC)综合征家族史的女性寻求基因检测。她被发现携带富马酸水合酶(FH)基因突变以及一个之前未被检测到的肾肿瘤。该患者接受了根治性肾切除术,随访时情况良好。HLRCC综合征是一种罕见的常染色体显性疾病,患者患皮肤平滑肌瘤、早发性子宫平滑肌瘤和侵袭性肾癌的风险增加。尽管该综合征可能会出现危及生命的并发症,但通过预防性家族筛查和监测、促使早期诊断,结局可能会得到改善。